Middle East & Africa Lyophilized Injectable Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)   

No. of Pages: 123    |    Report Code: BMIRE00027590    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Lyophilized Injectable Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Lyophilized Injectable Market – By Type of Packaging

1.3.2        MEA Lyophilized Injectable Market – By Type of Delivery

1.3.3        MEA Lyophilized Injectable Market – By Indication

1.3.4        MEA Lyophilized Injectable Market – By End User

1.3.5        MEA Lyophilized Injectable Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Lyophilized Injectable Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Lyophilized Injectable Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Demand for Contract Research Manufacturing Services

5.1.2        Increasing Demand of Biologics

5.2         Market Restraints

5.2.1        Product Recalls

5.3         Market Opportunities

5.3.1        Expansion of Pipeline of Lyophilized Injectable Drugs

5.4         Future Trends

5.4.1        Advancement in Lyophilized Packaging

5.5         Impact Analysis

6.           Lyophilized Injectable Market– MEA Analysis

6.1         MEA Lyophilized Injectable Market Revenue Forecast and Analysis

7.           MEA Lyophilized Injectable Market Analysis – By Type of Packaging

7.1         Overview

7.2         MEA Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

7.3         Single-use vials

7.3.1        Overview

7.3.2        Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Point-of-Care Reconstitution

7.4.1        Overview

7.4.2        Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Specialty Packaging

7.5.1        Overview

7.5.2        Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.           MEA Lyophilized Injectable Market Analysis – By Type of Delivery

8.1         Overview

8.2         MEA Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

8.3         Prefilled Diluent Syringes

8.3.1        Overview

8.3.2        Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Single Step Devices

8.4.1        Overview

8.4.2        Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Proprietary Reconstitution Devices

8.5.1        Overview

8.5.2        Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Multi-Step Devices

8.6.1        Overview

8.6.2        Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.           MEA Lyophilized Injectable Market Analysis – By Indication

9.1         Overview

9.2         MEA Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

9.3         Metabolic and Oncology Conditions

9.3.1        Overview

9.3.2        Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Autoimmune Diseases

9.5.1        Overview

9.5.2        Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Indications

9.6.1        Overview

9.6.2        Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.        MEA Lyophilized Injectable Market Analysis – By End User

10.1      Overview

10.2      MEA Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Specialty Clinics

10.5.1     Overview

10.5.2     Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Other End Users

10.6.1     Overview

10.6.2     Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.        MEA Lyophilized Injectable Market – Country Analysis

11.1      Overview

11.1.1     MEA: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.1.1.1       South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.1       Overview

11.1.1.1.2       South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.3       South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.1.4       South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.1.5       South Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.1.6       South Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.2       Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.1       Overview

11.1.1.2.2       Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.3       Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.2.4       Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.2.5       Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.2.6       Saudi Arabia: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.3       UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.1       Overview

11.1.1.3.2       UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.3       UAE: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.3.4       UAE: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.3.5       UAE: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.3.6       UAE: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.4       Rest of MEA: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of MEA: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.4.3       Rest of MEA: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.4.4       Rest of MEA: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.4.5       Rest of MEA: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.4.6       Rest of MEA: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Baxter

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nipro

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Recipharm AB

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Vetter Pharma

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Jubilant HollisterStier (Jubilant Pharma Limited)

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Aristopharma Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Credence MedSystems, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      S.G. Biopharm Pvt. Ltd.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             MEA Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             South Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             South Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             South Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             South Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Saudi Arabia: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          UAE: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          UAE: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          UAE: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          UAE: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14.          Rest of MEA: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15.          Rest of MEA: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16.          Rest of MEA: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17.          Rest of MEA: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 18.          Recent Inorganic Growth Strategies

Table 19.          Recent Organic Growth Strategies

Table 20.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           MEA Lyophilized Injectable Market Segmentation

Figure 2.           MEA Lyophilized Injectable Market – By Country

Figure 3.           MEA Lyophilized Injectable Market Overview

Figure 4.           MEA Lyophilized Injectable Market, By Type of Packaging

Figure 5.           MEA Lyophilized Injectable Market, By Country

Figure 6.           MEA: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           MEA Lyophilized Injectable Market Impact Analysis of Drivers and Restraints

Figure 9.           MEA Lyophilized Injectable Market– Revenue Forecast and Analysis

Figure 10.        MEA Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

Figure 11.        MEA Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        MEA Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        MEA Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

Figure 15.        MEA Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

Figure 20.        MEA Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        MEA Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        MEA Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        MEA Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

Figure 25.        MEA Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        MEA Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        MEA: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 30.        MEA: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

Figure 31.        South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32.        Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 33.        UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 34.          Rest of MEA: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

The List of Companies - Middle East & Africa Lyophilized Injectable Market

  1. Aristopharma Ltd.
  2. Baxter
  3. Credence MedSystems, Inc.  
  4. Jubilant HollisterStier (Jubilant Pharma Limited)
  5. Nipro
  6. Recipharm AB
  7. S.G. Biopharm Pvt. Ltd.  
  8. Vetter Pharma